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OBJECTIVES: The current study sought to identify macroscopic placental changes associated with clinical conditions
in women with or without diabetes and their newborns.
METHODS: The study population consisted of 62 pregnant women clinically diagnosed with diabetes and 62 healthy
women (control group).
RESULTS: Among the subjects with diabetes, 43 women (69.3%) were diagnosed with gestational diabetes mellitus,
15 had diabetes mellitus I (24.2%), and four had diabetes mellitus II (6.5%). The mean age of the women studied
was 28.5¡5.71 years, and the mean gestational age of the diabetic women was 38.51 weeks. Of the 62 placentas
from diabetic pregnancies, 49 (79%) maternal surfaces and 59 (95.2%) fetal surfaces showed abnormalities,
including calcium and fibrin deposits, placental infarction, hematoma, and fibrosis. A statistical association was
found between newborn gender and fetal and maternal placental changes (p=0.002). The mean weight of the
newborns studied was 3,287¡563 g for women with diabetes mellitus, 3,205¡544 g for those with gestational
diabetes mellitus, 3,563¡696 g for those with diabetes mellitus II, and 3,095¡451 g for those with diabetes mellitus I.
CONCLUSIONS: Infarction, hematoma, calcification, and fibrin were found on the maternal and fetal placental
surfaces in women with diabetes. Women with gestational diabetes and post-term infants had more calcium
deposits on the maternal placental surface as compared to those with type I and type II diabetes.
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INTRODUCTION
The human placenta regulates maternal and fetal physio-
logical changes during pregnancy. It also plays a major role
in pregnancy-related complications, such as diabetes melli-
tus (DM) (1).
DM is a common clinical condition that affects approxi-
mately 1 to 15% of pregnant women. Maternal metabolic
control has been directly associated with complications and
deaths in pregnant women with DM (2). Diabetes during
pregnancy can lead to or aggravate placental abnormalities,
which will impact the systemic balance between the
pregnant woman and her fetus. DM can increase the
frequency of placental dysfunction and alter its structure
and function, and it is also associated with increased rates of
maternal and perinatal morbidity and miscarriage. The
nature, extent, and specificity of these abnormalities depend
on the gestational period and the severity and type of
diabetes.
Although the mechanisms of pathogenesis are not fully
understood, it is believed that hormonal adjustments during
pregnancy, including increased levels of estrogen, proges-
terone, cortisol, prolactin, and human placental lactogen,
play an important role. These changes lead to metabolic
imbalance and may result in increased insulin resistance
and DM onset in susceptible women and uncontrolled
blood glucose levels in pre-diabetic women, especially
during the last two trimesters of pregnancy (3).
DM complications during pregnancy include polyhydram-
nios (clinically diagnosed in pregnant women with poorly
controlled DM); premature rupture of membranes and pre-
term births (4); hypertensive disorders of pregnancy, parti-
cularly preeclampsia (5); and higher rates of spontaneous
abortion, macrosomia (6), birth defects, stillbirth, respiratory
distress syndrome, and neonatal hypoglycemia (4).
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Placental changes are believed to be partly responsible for
the high incidence of fetal complications observed in
pregnant women with DM (1). However, the relationship
between DM and the macroscopic placental changes that
occur during pregnancy is not well established. Thus, the
current study aimed to identify macroscopic placental
changes associated with clinical outcomes in women with
and without DM and their newborns.
MATERIALS AND METHODS
This prospective study was conducted at a public
maternity hospital and diabetes reference center in the city
of Goiaˆnia in Central-West Brazil between August 2009 and
July 2010. The study population included 62 pregnant
women clinically diagnosed with DM. These women were
matched to a control group that comprised 62 healthy
women considered to be at a low obstetric risk who had
undergone vaginal delivery or cesarean section. These
women had no maternal complications during pregnancy,
their obstetric and laboratory tests were normal, and they
had clinically normal babies born at term.
The following exclusion criteria were applied: women with
infectious diseases, placentas in formaldehyde, cases of
stillbirths and intrauterine fetal deaths, pregnant women
with autoimmune diseases or other diseases that could lead to
immunological changes, and those who received corticoster-
oid therapy during labor. Stillborn fetuses were defined as
any fetus at a gestational age of at least 22 weeks and/or fetal
weight $500 g whose death occurred before complete
separation from the maternal body and who did not show
any of the following signs compatible with life at birth:
heartbeat, umbilical cord pulsation, or voluntary muscle
movements (7). The control group comprised pregnant
women who did not experience complications during
pregnancy and who had normal laboratory tests and clinically
normal newborns.
We evaluated all macroscopic changes on the fetal and
maternal placental and umbilical cord surfaces. All lesions
were examined, recorded, and photographed.
The evaluation of macroscopic placental parameters was
performed according to protocols published by Driscoll and
Langston (1991) (8) and Benirsckhe and Kaufmann (1995)
(9).
Data were collected from medical records and transcribed
into study forms. We collected information about obstetric
history; potential neonatal/fetal and maternal obstetric
complications; neonatal anthropometric measurements, 1-
and 5-minute Apgar scores; laboratory tests for the eva-
luation of DM; parity; and gestational age, which was
determined according to the date of the last menstrual
period, the first trimester ultrasound examination, and the
Capurro method. When the results of the gestational age
assessment were inconsistent, the results of the Capurro
method (10) were used. Underlying maternal conditions
were grouped according to the 10th Revision of International
Classification of Diseases (ICD-10) criteria, and neonatal/
fetal underlying conditions were grouped according to the
Cartlidge and Stewart criteria (7).
Statistical analyses were performed with SigmaStatH
version 2.0 (San Jose, California, USA), and an electronic
spreadsheet was created. Categorical variables are presented
as absolute (n) and relative values (percentages). Proportions
were compared using the Yates’ correction or chi-squared
(x2) and Fisher’s exact tests. Differences of p,0.05 were
considered statistically significant.
The research project was approved by the Research Ethics
Committee of the Federal University of Goia´s (UFG) and
was registered in the U.S. National Institutes of Health
website (protocol number 101/2008).
RESULTS
Regarding the type of diabetes, 43 women (69.3%) were
diagnosed with gestational diabetes mellitus (GDM), 15
were diagnosed with DM I (24.2%) and 4 were diagnosed
with DM II (6.5%). The mean age of the women studied was
28.5¡5.71 years, and there was no statistical correlation
between maternal age and maternal placental changes. There
was a higher proportion of multigravida than secundigra-
vida and primigravida women (23 cases [37.1%], 11 cases
[17.7%], and 9 cases [14.5%], respectively) among women
with GDM.
Of the 62 placentas that were macroscopically examined,
49 (79%) maternal surfaces and 59 (95.2%) fetal surfaces
showed changes, including calcium and fibrin deposits,
placental infarction, hematoma, and fibrosis (Table 1).
Calcification was predominantly observed on the mater-
nal surface of 35 placentas (56.4%), although hematoma and
fibrosis were not detected on the maternal surface. A greater
number of placental changes were observed in pregnant
women with GDM: 31 (50%) were detected on the maternal
surface (Table 1) and 40 (64.5%) were detected on the fetal
surface (Table 2).
The most common pathological change found on the fetal
surface was the presence of fibrin, which was observed in 51
placentas (82.3%). Placental infarction and fibrosis were not
found on the fetal surface (Table 2). The assessment of an
association between GDM and placental changes showed
that all 43 women with GDM (100%) demonstrated some
sort of change in either the fetal or maternal placental
surface. The most common placental changes included
calcification (19; 44.1%), fibrin (11; 25.6%), and placental
infarction (1; 2.3%) on the maternal surface; and fibrin (35;
81.4%), calcification (4; 9.3%), and hematoma (1; 2.3%) on
the fetal surface. There were no placental changes on the
maternal surface in 12 cases (28%) and on the fetal surface in
three cases (7%).
Table 1 - Distribution of placental macroscopic changes
on the maternal surface in 62 pregnant women with
diabetes mellitus from Goiaˆnia, Central-West Brazil,
between August 2009 and July 2010.
Maternal
surface
alterations DM
GDM DM I DM II
n (%) n (%) n (%)
Calciphylaxis 19 (44.2) 13 (86.6) 3 (75)
Fibrin 11 (25.6) 1 (6.7) 1 (25)
Infarction 1 (2.3) 0 (0) 0 (0)
No alterations 12 (27.9) 1 (6.7) 0 (0)
DM = diabetes mellitus, GDM = gestational diabetes mellitus, DM I =
type I diabetes mellitus, DM II = type II diabetes mellitus, n = number of
cases.
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Women with GDM had a greater amount of hydroxyapa-
tite (calciphylaxis) deposited on the maternal placental
surface as compared to those without DM (p= 0.008) (Table 3).
Among women with DM, there was a higher proportion
of full-term births (45 cases, 72.6%), followed by pre-term
(15 cases, 24.2%) and post-term births (two cases, 3.2 %)
(Table 4).
No statistically significant relationship was found between
fetal and maternal placental changes and gestational age. The
mean gestational age among women with DM was 38.51
weeks. Table 5 shows the associations between gestational
age and types of DM. Full-term births were more common
among women with all types of DM: 29 full-term births
(64.4%) occurred in women with GDM; 12 (26.7%) occurred
in those with DM I; and four (8.9 %) occurred in those with
DM II. There was no statistically significant relationship
between gestational age and type of DM (Table 5).
A statistical association was found between newborn
gender and fetal and maternal placental changes. Women
who gave birth to females had more calcification on the
maternal placental surface as compared to other groups
(p= 0.002). In addition, larger fibrin deposits on the maternal
placental surface were associated with mothers of male
newborns (p,0.001), and placental macroscopic changes
were less common in mothers with female newborns
(p= 0.021). There was also a predominance of male (33,
53.2%) as compared to female (29, 46.8%) newborns born to
the women in our study.
The mean newborn weight was 3,287¡563 g in women
with DM; 3,205¡544 g in those with GDM, 3,563¡696 g in
those with DM II, and 3,095¡451 g in those with DM I.
There was no statistically significant association between
newborn weight and type of maternal DM (Table 6).
The mean 1- and 5-minute Apgar scores in newborns born
to mothers with DM were 7.6¡1.6 and 9.5¡0.6, respec-
tively. The mean 1- and 5-minute Apgar scores of newborns
of women with GDM, DM I and DM II were 7.8¡1.3 and
9.2¡0.6, 7.4¡2.4 and 9.5¡0.7, and 7.7¡1.2 and 9.7¡0.5,
respectively.
DISCUSSION
Several changes occur in the human placenta during
pregnancies that are complicated by DM. These abnormal-
ities are directly associated with intrauterine blood glucose
levels that lead to reduced maternal-placental blood
circulation and maternal-fetal exchange (11). Both macro-
scopic and microscopic pathological changes are associated
with complications during pregnancy. For example, clinical
and obstetric complications accelerate placental calcification
due to stress mechanisms (12).
The results of the current study demonstrated a significant
association between fibrin deposits on the fetal surface of the
placenta and full-term newborns. However, a previous study
with a similar sample size presented findings that contrast with
those presented here (13), and another publication reported
that fertility in women with DM may be affected through
different mechanisms. Preimplantation human conceptuses are
sensitive to insulin and may be directly affected by maternal
insulin resistance, and rat models have shown that excess
Table 2 - Distribution of placental macroscopic changes
on the fetal placental surface in 62 pregnant women with
diabetes mellitus from Goiaˆnia, Central-West Brazil,
between August 2009 and July 2010.
Fetal surface
alterations DM
GDM DM I DM II
n (%) n (%) n (%)
Calciphylaxis 4 (9.3) 3 (20) 0 (0)
Fibrin 35 (81.4) 12 (80) 4 (100)
Infarction 1 (2.3) 0 (0) 0 (0)
No alterations 3 (7.0) 0 (0) 0 (0)
DM = diabetes mellitus, GDM = gestational diabetes mellitus, DM I =
type I diabetes mellitus, DM II = type II diabetes mellitus, n = number of
cases.
Table 3 - Association between macroscopic changes on the fetal and maternal placental surfaces and gestational
diabetes mellitus in 43 women from Goiaˆnia, Central-West Brazil, between August 2009 and July 2010.
MACROSCOPIC ALTERATIONS GDM
MATERNAL SURFACE p-value FETAL SURFACE p-value
Calcification Yes No Yes No
Yes 19 24 0.008 4 39 0.665
No 16 3 3 16
Fibrin
Yes 11 32 0.310 35 8 1.000
No 2 17 16 3
Placental infarction
Yes 1 42 1.000 0 43 1.000
No 0 19 0 19
Hematoma
Yes 0 43 1.000 1 42 1.000
No 0 19 0 19
Fibrosis
Yes 0 43 1.000 0 43 1.000
No 0 19 0 19
No alterations
Yes 12 31 0.050 3 40 0.546
No 1 18 0 19
Fisher’s exact test.
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insulin leads to reduced preimplantation. Although findings in
rat models cannot be directly applied to humans, they provide
information on how insulin resistance may affect fertility (14).
Studies of vascular systems have shown that high glucose
and insulin levels profoundly affect vascular endothelial
growth factor, nitric oxide and protein kinase C levels, as
well as alterations in junctional adhesion molecules, such as
occludin and vascular endothelial-cadherin, which cause
vascular albumin leakage. Increased superoxide and nitric
oxide production may also induce placental oxidative stress
via the effects of prooxidant peroxynitrite, which itself leads
to vascular dysfunction (15). Nitrotyrosine residues are
found in placental vessels of preeclamptic and diabetic
pregnancies, which further highlight the effects of oxidative
stress in these conditions (16). Moreover, the abnormal
molecular mechanisms underlying vascular changes in the
diabetic human placenta may be consequences of high
glucose and hyperinsulinemia (15).
With regard to gestational age, Sgrott (17) reported a
mean gestational time of 38.51 weeks at birth in women with
DM, which is similar to what we observed in the current
study. However, some studies have claimed that DM may
cause pre-term births (less than 38 weeks of gestation) (18).
Pregnant women diagnosed with DM are at an increased
risk of clinical and obstetric complications, such as pre-term
delivery, gestational hypertension, urinary tract and other
infections, periodontal disease, cesarean delivery, and obste-
tric trauma. Pre-term delivery before 35 weeks of gestation is
directly related to the severity of diabetes and proteinuria in
early gestation (19). Furthermore, one-third of all premature
births in women with DM are a consequence of hypertensive
complications. The factors involved in increased spontaneous
pre-term births in women with DM are not yet clearly
understood, although they have been associated with poor
blood glucose control, polyhydramnios, and infection (20). It is
believed that hospital management of women with DM may
have contributed to a decrease in the number of premature
births, although no reports on the relationship between DM
and post-term births could be found in the literature.
In the current study, the control group demonstrated a
high number of premature births, which we believe may
have been because the study hospital serves a population of
high-risk pregnant women. Although these women did not
have clinical DM, they may have had other abnormalities
that could have predisposed them to pre-term delivery and
premature rupture of membranes, including urinary tract
infections, polyhydramnios, and high blood pressure.
Regarding gestational age, one study found that new-
borns of mothers with DM I were born at lower gestational
ages than those of mothers with GDM (21). In a similar
study, the 1- and 5-minute Apgar scores of infants from
women with DM I, DM II and GDM were 5¡2 and 9¡0.5,
8¡1.5 and 10¡0.5, and 9¡1.5 and 10¡0.5, respectively
(22). In our study, there was no statistically significant
relationship between Apgar scores and the type of maternal
DM.
The literature provides conflicting results on Apgar
scores. For example, one study found no significant
difference in 1- and 5-minute Apgar scores of newborns
from mothers with DM as compared to a control group (23),
whereas another publication showed that placental changes
consistent with reduced blood flow were associated with
lower 1- and 5-minute Apgar scores (24).
The mean weight of newborns from women with DM II
was higher than that of newborns from women with GDM
and DM I. Neither our study nor that of Szylit et al. (21)
found any significant differences in the mean weights of
newborns born to women with different types of DM.
Fetal macrosomia, which is commonly defined as a birth
weight of more than 4.000 g, is the most common fetal
Table 4 - Distribution of gestational age for 62 women with or without (control of) diabetes mellitus, according to
diabetes type, from Goiaˆnia, Central-West Brazil, between August 2009 and July 2010.
GESTATIONAL AGE GDM DM I DM II CONTROL
n (%) n (%) n (%) n (%)
Pre-term 12 (28) 3 (20) 0 (0) 25 (40.3)
Full-term 29 (67.4) 12 (80) 4 (100) 23 (37.1)
Post-term 2 (4.6) 0 (0) 0 (0) 14 (22.6)
DM = diabetes mellitus, GDM = gestational diabetes mellitus, DM I = type I diabetes mellitus, DM II = type II diabetes mellitus, n =number of cases
CONTROL: women without DM. ANOVA: F = 7.282 (p=0.02), followed by Dunnett’s method (p,0.05) (control vs. DM II, control vs. DM I).
Table 5 - Gestational ages for 62 pregnant women with different types of diabetes mellitus from Goiaˆnia, Central-West
Brazil, between August 2009 and July 2010.
GESTATIONALAGE DM
GDM p-value DM I p-value DM II p-value
,38 weeks of gestation Yes No Yes No Yes No
Yes 12 3 0.356 3 12 0.214 0 15 0.564
No 31 16 12 35 4 43
38-40 weeks of gestation
Yes 29 16 0.291 12 33 0.528 4 41 0.568
No 14 3 3 14 0 17
.40 weeks of gestation
Yes 2 0 1.000 0 2 1.000 0 2 1.000
No 41 19 15 45 4 56
Fisher’s exact test. DM = diabetes mellitus, GDM = gestational diabetes mellitus, DM I = type I diabetes mellitus, DM II = type II diabetes mellitus, n =
number of cases.
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complication of maternal DM. This condition increases the
risk of perineal lacerations and delivery complications (fetal
dystocia) that often necessitate cesarean section. There is
also a high risk of immediate complications for infants born
to mothers with DM, including intracranial hemorrhage,
shoulder dystocia, neonatal hypoglycemia, jaundice, and
respiratory distress (25). These infants are also at an
increased risk of long-term complications. Early nutritional
adjustments during gestation can permanently alter carbo-
hydrate metabolism and cause adult-onset disorders. In
addition, high birth weight is a predisposing factor for
insulin resistance, obesity and DM II during childhood, as it
reflects inadequate glucose control that is often due to
delayed prenatal care (18). Childhood obesity has become a
major public health concern, and the population of over-
weight children in Brazil increases by 0.5% annually (26).
In conclusion, we observed infarction, hematoma, calci-
fication, and fibrin on the maternal and fetal placental
surfaces of women with DM. In addition, women with
GDM and post-term infants had more calcium deposits on
the maternal placental surface of the placenta, and mothers
of female newborns had a larger number of calcium and
fibrin deposits on the maternal placental surface.
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